NCT00336349View on ClinicalTrials.gov

A Study of Intra-dermal Injection of Botulinum Toxin Type A for the Diabetic Neuropathic Foot Pain

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Diabetes MellitusNeuropathic Pain
Interventions
DRUG

Botulinum Toxin Type A

Botulinum Toxin Type A

Trial Locations (1)

106

Chaur-Jong Hu, Taipei

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Taipei Medical University Hospital

OTHER